PetaGene

PetaGene provides transparent genomic compression, making clinical diagnostics speedier and more affordable, and enabling researchers across the world to move faster and store more of their sequenced data than ever before.\n\nGenetic Sequencing is poised to become a routine part of clinical diagnostics, with many leadi

PetaGene is a business in biotechnology research based in Cambridge, London, UK, founded in 2016.

Profile

PetaGene provides transparent genomic compression, making clinical diagnostics speedier and more affordable, and enabling researchers across the world to move faster and store more of their sequenced data than ever before.\n\nGenetic Sequencing is poised to become a routine part of clinical diagnostics, with many leading hospitals already adopting Precision Medicine initiatives. As the cost of whole genome sequencing has fallen from $300 mil in 2003 to about $600 today, it has unleashed a flood of genomic data, making IT challenges a critical pain point for adoption.\n\nPetaGene empowers leading biopharma, academic and other researchers in their ability to investigate cancer, rare diseases and develop early warning diagnostics.\n\nhttp://www.petagene.com/wp-content/uploads/2017/10/PetaSuite-datasheet.pdf

As a business in biotechnology research, PetaGene is listed here with the public details available about it.

Cambridge, London, UK is where the company is located.

The company is listed at the HackerNoon Startups of the Year stage of development.

Recorded headcount: 11-50 employees.

Website: petagene.com